In an interview with Applied Clinical Trials Associate Editor Don Tracy, Samuel Salvaggio Senior Trial Design Lead, One2Treat, discusses partnerships that remain vital for guaranteeing success in ...

Through their combined expertise, the two entities are poised to introduce advancements in clinical trials and medical services.

Trump’s tariffs are set to impact all sectors in some capacity, including clinical trials. With the US President placing a 10 ...

National Institutes of Health grants are essential for lifesaving medical research. A Trump administration policy now ...

Flourish is an Apex, North Carolina-based multi-site clinical trial organization focused primarily on cardiovascular, metabolic, neuroscience, and infectious disease therapeutic areas.

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

USAID's stop-work order threatens to undo decades of progress in medical research ethics and cause harm to clinical trial ...

Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary ...

TotalEnergies has launched a pilot project in Utrecht to test dynamic charging tariffs. During the trial phase, tariffs at 15 ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir—the company’s twice-yearly ...

CBD has shown promise as a treatment for psychosis in small studies and case reports. A large, international trial launching ...

Vistagen Therapeutics' Q3 2025 earnings reveal progress on Phase 3 trials for social anxiety drug fasedienol, innovative therapies, and strong ...